Percutaneous ethanol injection therapy (PEIT) is a useful and safe treatment alternative for patients with persistent post-transplant secondary hyperparathyroidism, researchers in Argentina report.

ELEVATED BMI is associated with secondary hyperparathyroidism in non-dialysis CKD patients, especially patients who have evidence of malnutrition and inflammation, a study found.

HYPERPARATHYROIDISM IS common in long-term transplant recipients, findings suggest.

Paricalcitol decreases intact parathyroid hormone (iPTH) levels in children receiving hemodialysis while not causing significant changes in serum calcium, phosphorus, or Ca x P product values, a study found.

BONE MINERAL density (BMD) may be reduced and parathyroid hormone (PTH) levels elevated in long-term renal transplant patients with good graft function, according to Swedish researchers.